What is CVE-2023-26097?

CVE-2023-26097 is a high-severity vulnerability in Telindus Apsal, classified under Incorrect Authorization. CVSS score: 8.4/10. Published 2023-04-24.

How severe is CVE-2023-26097?

High severity. CVSS v3 base score is 8.4 out of 10.

Auth bypass in Telindus Apsal

CVE-2023-26097

An issue was discovered in Telindus Apsal 3.14.2022.235 b. Unauthorized actions that could modify the application behaviour may not be blocked.

Vulnerability class: Broken Access Control

Published 2023-04-24 · last modified 2026-06-17.

CVSS v3 metric

CVSS v3 base score 8.4 (High). Vector: CVSS:3.1/AV:L/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H.

EPSS exploit prediction

EPSS: 0.002 (7.6th percentile), scored 2026-10-01.

Very low probability of exploitation in the next 30 days; routine patching cadence is appropriate. 8th percentile — 7.6% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.

EPSS over last 30 days · oldest: 0.002 · newest: 0.002 · change: 0.000

Affected products

Telindus Apsal — versions 3.14.2022.235_b

Weakness classification (CWE)

CWE-863 — Incorrect Authorization

References

www.telindus.lu/fr/produits/apsal (Product)
excellium-services.com/cert-xlm-advisory/CVE-2023-26097 (Third Party Advisory)
cds.thalesgroup.com/en/tcs-cert/CVE-2023-26097

Frequently asked questions

What is CVE-2023-26097?: CVE-2023-26097 is a high-severity vulnerability in Telindus Apsal, classified under Incorrect Authorization. CVSS score: 8.4/10. Published 2023-04-24.
How severe is CVE-2023-26097?: High severity. CVSS v3 base score is 8.4 out of 10.